NasdaqGM - Delayed Quote USD

Phibro Animal Health Corporation (PAHC)

Compare
23.12 -0.58 (-2.45%)
At close: October 31 at 4:00 PM EDT
23.12 0.00 (0.00%)
After hours: October 31 at 4:17 PM EDT
Loading Chart for PAHC
DELL
  • Previous Close 23.70
  • Open 23.53
  • Bid 16.72 x 200
  • Ask 29.81 x 200
  • Day's Range 23.12 - 23.68
  • 52 Week Range 9.40 - 25.11
  • Volume 93,858
  • Avg. Volume 182,606
  • Market Cap (intraday) 959.51M
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) 385.33
  • EPS (TTM) 0.06
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield 0.48 (2.07%)
  • Ex-Dividend Date Sep 4, 2024
  • 1y Target Est 16.80

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

www.pahc.com

1,940

Full Time Employees

June 30

Fiscal Year Ends

Recent News: PAHC

View More

Performance Overview: PAHC

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

PAHC
104.07%
S&P 500
19.62%

1-Year Return

PAHC
118.54%
S&P 500
36.93%

3-Year Return

PAHC
15.76%
S&P 500
23.89%

5-Year Return

PAHC
12.18%
S&P 500
87.26%

Compare To: PAHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PAHC

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    937.25M

  • Enterprise Value

    1.35B

  • Trailing P/E

    385.67

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.92

  • Price/Book (mrq)

    3.65

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    19.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.24%

  • Return on Assets (ttm)

    3.80%

  • Return on Equity (ttm)

    0.90%

  • Revenue (ttm)

    1.02B

  • Net Income Avi to Common (ttm)

    2.42M

  • Diluted EPS (ttm)

    0.06

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    127.76M

  • Total Debt/Equity (mrq)

    206.77%

  • Levered Free Cash Flow (ttm)

    55.17M

Research Analysis: PAHC

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 273.16M
Earnings 752k
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.00 Low
16.80 Average
23.12 Current
22.00
 

Company Insights: PAHC

Research Reports: PAHC

View More
  • Lowering target price to $26.00

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of BUY; a target price of $26.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • What does Argus have to say about PAHC?

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of BUY; a target price of $27.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • Raising target price to $27.00

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of BUY; a target price of $27.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of High; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     
  • What does Argus have to say about PAHC?

    PHIBRO ANIMAL HEALTH CORP-A has an Investment Rating of BUY; a target price of $24.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.

    Rating
    Price Target
     

People Also Watch